Identification and quantitation of N,α-diethylphenethylamine in preworkout supplements sold via the Internet

Forensic Toxicology

Volumn 32, Issue 1, 2014, Pages 148-153

  Lee, Jaesin ^a   Venhuis, Bastiaan J ^b   Heo, Sewoong ^a   Choi, Hyeyoung ^a   Seol, Ilung ^a   Kim, Eunmi ^a  

^a National Forensic Service   (South Korea)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

Craze; Designer drug; GC MS; N, Diethylphenethylamine (NADEP); NMR; Preworkout supplement

Indexed keywords

EID: 84895147692     PISSN: 18608965     EISSN: 18608973     Source Type: Journal    
DOI: 10.1007/s11419-013-0205-6     Document Type: Article

References (21)

1. Lau G, Lo DST, Yao YJ, Leong HT, Chan CL, Chu SS (2004) A fatal case of hepatic failure possibly induced by nitrosofenfluramine: a case report. Med Sci Law 44:252-263
2. WADA (2013) The 2013 prohibited list. World Anti-Doping Agency, Montreal
3. Zhang Y, Woods RM, Breitbach ZS, Armstrong DW (2012) 1,3- Dimethylamylamine (DMAA) in supplements and geranium products: natural or synthetic? Drug Test Anal 4:986-990
4. Kelleher C, Christie R, Lalor K, Fox J, Bowden M, O'Donnell C (2011) An overview of new psychoactive substances and the outlets supplying them. National Advisory Committee on Drugs (NACD), Dublin
5. Thomas JE, Munir JA, Mclntyre PZ, Ferguson MA (2009) STEMI in a 24-year-old man after use of a synephrine-containing dietary supplement: a case report and review of the literature. Tex Heart Inst J 36:586-590
6. Lee J, Choe S, Choi H, Heo S, Kim E, Kim H, Bang E, Chung H (2013) Identification of N-ethyl-α-ethylphenethylamine in crystalline powder seized for suspected drug trafficking: a research chemical or a new designer drug? Forensic Toxicol 31:54-58
7. Gadape HH, Parikh KS (2011) Quantitative determination and validation of metformin hydrochloride in pharmaceutical using quantitative nuclear magnetic resonance spectroscopy. E-J Chem 8: 767-781. http://dx.doi.org/10.1155/2011/ 46898
8. Gadape HH, Parikh KS (2011) Quantitative determination and validation of pioglitazone in pharmaceutical using quantitative nuclear magnetic resonance spectroscopy. J Chem Pharm Res 3:649-664
9. Miller JN, Miller JC (2005) Statistics and chemometrics for analytical chemistry, 5th edn. Pearson Education, Harlow
10. Peters FT, Drummer OH, Musshoff F (2007) Validation of new methods. Forensic Sci Int 165:216-224
11. József K, Antal S, Éva S, Éva S, Zoltán T, Károly M, János B (1988) New psychostimulant agent. International application published under the patent cooperation treaty (PCT). World Intellectual Property Organization (WIPO), Publication No. WO 88/02254
12. Noggle FT, Clark CR, Pitts-Monk P, DeRuiter J (1991) Liquid chromatographic and mass spectral analysis of 1-phenyl-2-butanamines: homologues of the amphetamines. J Liq Chromatogr 14:1393-1408
13. Ricaurte GA, DeLanney LE, Irwin I, Witkin JM, Katz JL, Langston JW (1989) Evaluation of the neurotoxic potential of N, N-dimethylamphetamine: an illicit analog of methamphetamine. Brain Res 490:301-306
14. Junet R (1956) Ethylamphetamine in the treatment of obesity (in French). Praxis 45:986-988
15. Oberlender R, Nichols DE (1991) Structural variation and (+)-amphetamine like discriminative stimulus properties. Pharmacol Biochem Behav 38:581-586
16. Nichols DE (1986) Differences between the mechanism of action of MDMA, MBDB, and the classic hallucinogens. Identification of a new therapeutic class: entactogens. J Psychoact Drugs 18:305-313
17. Suzuki O, Hattori H, Asano M, Oya M, Katsumata Y (1980) Inhibition of monoamine oxidase by d-methamphetamine. Biochem Pharmacol 29:2071-2073
18. ® immunoassays. Forensic Toxicol 31:133-137
19. Pirisi MA, Nieddu M, Burrai L, Carta A, Briguglio I, Baralla E, Demontis MP, Varoni MV, Boatto G (2013) An LC-MS-MS method for quantitative analysis of six trimethoxyamphetamine designer drugs in rat plasma, and its application to a pharmacokinetic study. Forensic Toxicol 31:197-203
20. Nakazono Y, Tsujikawa K, Kuwayama K, Kanamori T, Iwata YT, Miyamoto K, Kasuya F, Inoue H (2013) Differentiation of regioisomeric fluoroamphetamine analogs by gas chromatography-mass spectrometry and liquid chromatography-tandem mass spectrometry. Forensic Toxicol 31:241-250
21. Zaitsu K, Miyagawa H, Sakamoto Y, Matsuta S, Tsuboi K, Nishioka H, Katagi M, Sato T, Tatsuno M, Tsuchihashi H, Suzuki K, Ishii A (2013) Mass spectrometric differentiation of the isomers of mono-methoxyethylamphetamines and mono-methoxydimethylamphetamines by GC-EI-MS-MS. Forensic Toxicol 31:292-300